Overview

Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS

Status:
Unknown status
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Rosuvastatin reload may prevent myocardial damage in ACS patients undergoing PCI
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Anzhen Hospital
Treatments:
Rosuvastatin Calcium